Skip to content

Management of Hepatocellular Carcinoma *

Jordi Bruix, Morris Sherman

Hepatology · 2005 · 5,941 citationsOpen access

No retraction on record in OpenAlex.Check Crossref now

Cite this paper

Bruix, J., & Sherman, M. (2005). Management of hepatocellular carcinoma *. Hepatology, 42(5), 1208–1236. https://doi.org/10.1002/hep.20933

In text: (Bruix & Sherman, 2005)

Ask a question about this research

One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.

Abstract

PreambleThese recommendations provide a data-supported approach to the diagnosis, staging and treatment of patients diagnosed with hepatocellular carcinoma (HCC).They are based on the following: (a) formal review and analysis of the recently-published world literature on the topic (Medline search through early 2005); (b) American College of Physicians Manual for Assessing Health Practices and Designing Practice Guidelines. 1 (c) guideline policies, including the AASLD Policy on the Development and Use of Practice Guidelines and the AGA Policy Statement on Guidelines 2 ; (d) the experience of the authors in the specified topic.We have also reviewed the guidelines prepared at the time of the Monothematic Conference of the European Association for the Study of the Liver (EASL) 3 and the practice of authors experienced in the field.Intended for use by physicians, these recommendations suggest preferred approaches to the diagnostic, therapeutic, and preventive aspects of care.They are intended to be flexible, in contrast to standards of care, which are inflexible policies to be followed in every case.Specific recommendations are based on relevant published information.In an attempt to characterize the quality of evidence supporting recommendations, the Practice Guidelines Committee of the AASLD requires a category to be assigned and reported with each recommendation (Table 1).These recommendations are fully endorsed by the American Association for the Study of Liver Diseases.

  1. Management of Hepatocellular Carcinoma: An Update Δσ2011
  2. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases2018
  3. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance2018
  4. Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line1999

Metadata from OpenAlex (CC0). Citations are generated from the published record.